(Q57609151)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jesus Ciriza

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hugo Ramírez Álvarez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

María Jesús Grillo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sergio Rosati

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lluís Luján

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

X de Andrés

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

H Crespo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

I Glaria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M M Pérez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

V Andrésdóttir

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

M Suzan-Monti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

B A Blacklaws

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

G D Harkiss

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

D de Andrés

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

B Amorena

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

16 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

4591-4600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

Biology and pathogenesis of lentiviruses

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Viral load, organ distribution, histopathological lesions, and cytokine mRNA expression in goats infected with a molecular clone of the caprine arthritis encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Quantitative analysis of maedi-visna virus DNA load in peripheral blood monocytes and alveolar macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Ovine lentivirus (maedi-visna virus) protein expression in sheep alveolar macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Prevention strategies against small ruminant lentiviruses: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

DNA vaccines: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Failure of experimental vaccines to protect against infection with ovine progressive pneumonia (maedi-visna) virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

The effect of post-infection immunization on the severity of experimental visna

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Mucosal vaccination with an attenuated maedi-visna virus clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

B70 antigen is a second ligand for CTLA-4 and CD28.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

The interaction properties of costimulatory molecules revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Molecular cloning and mRNA tissue-expression of two isoforms of the ovine costimulatory molecule CD80 (B7-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Molecular cloning of multiple forms of the ovine B7-2 (CD86) costimulatory molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Association of CD80 and CD86 expression levels with disease status of Visna/Maedi virus infected sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Nucleotide sequence of EV1, a British isolate of maedi-visna virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Expression of the gp150 maedi visna virus envelope precursor protein by mammalian expression vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Reporter gene expression in dendritic cells after gene gun administration of plasmid DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Immune response to individual maedi-visna virus gag antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Differential infection efficiencies of peripheral lung and tracheal tissues in sheep infected with Visna/maedi virus via the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Cytotoxic T lymphocytes in protection against equine infectious anemia virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Plasmid DNA encoding caprine interferon gamma inhibits antibody response to caprine arthritis-encephalitis virus (CAEV) surface protein encoded by a co-administered plasmid expressing CAEV env and tat genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Immunoblot analysis of the antibody response to ovine lentivirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Fc receptor but not complement binding is important in antibody protection against HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Failure of neutralizing antibody to regulate CAE lentivirus expression in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

Severity of arthritis is predicted by antibody response to gp135 in chronic infection with caprine arthritis-encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

7 January 2021

Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

7 January 2021

Analysis of antibody responses to phenotypically distinct lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

7 January 2021

Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

7 January 2021

Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.080

7 January 2021

10.1016/J.VACCINE.2009.05.080

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19538997%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference